Therapeutic Effect of Repurposed Temsirolimus in Lung Adenocarcinoma Model.

Chang, Hsuen-Wen; Wu, Min-Ju; Lin, Zih-Miao; Wang, Chueh-Yi; Cheng, Shu-Yun; Lin, Yen-Kuang; Chow, Yen-Hung; Ch'ang, Hui-Ju; Chang, Vincent H S

Chang, Hsuen-Wen; Wu, Min-Ju; Lin, Zih-Miao; Wang, Chueh-Yi; Cheng, Shu-Yun; Lin, Yen-Kuang; Chow, Yen-Hung; Ch'ang, Hui-Ju; Chang, Vincent H S.

Afiliação

Chang HW; Laboratory Animal Center, Office of Research and Development, Taipei Medical University, Taipei, Taiwan.
Wu MJ; Laboratory Animal Center, Office of Research and Development, Taipei Medical University, Taipei, Taiwan.
Lin ZM; The PhD Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
Wang CY; Laboratory Animal Center, Office of Research and Development, Taipei Medical University, Taipei, Taiwan.
Cheng SY; Laboratory Animal Center, Office of Research and Development, Taipei Medical University, Taipei, Taiwan.
Lin YK; Biostatistics Research Center, Taipei Medical University, Taipei, Taiwan.
Chow YH; National Institutes of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Taiwan.
Ch'ang HJ; National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan.
Chang VHS; The PhD Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.

Front Pharmacol ; 9: 778, 2018.

Article em En | MEDLINE | ID: mdl-30087612

Palavras-chave

chemotherapy; drug repositioning; lung adenocarcinoma; mTOR inhibitor; temsirolimus

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Taiwan

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google